Literature DB >> 30202263

Gut Microbiota and Obesity: Potential Therapeutic Targets and Probiotic Treatment.

Nicole D White1.   

Abstract

The gut bacteria model attributes obesity to the variable makeup of gut microbiota and its ability to modulate host energy homeostasis, adiposity and inflammation. To counteract these deleterious effects, strains of probiotics have been developed to manipulate gut microbiomes and improve health. The current article explores the mechanisms by which gut microbiota modulate host metabolism and highlights recent human study data assessing the effects of probiotic supplementation on the prevention and treatment of obesity.

Entities:  

Keywords:  bacteria; gut; obesity; probiotics

Year:  2015        PMID: 30202263      PMCID: PMC6125095          DOI: 10.1177/1559827615619586

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN: 1559-8276


  13 in total

Review 1.  Challenges in the addition of probiotic cultures to foods.

Authors:  Claude P Champagne; Nancy J Gardner; Denis Roy
Journal:  Crit Rev Food Sci Nutr       Date:  2005       Impact factor: 11.176

Review 2.  Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.

Authors:  Federica Molinaro; Elena Paschetta; Maurizio Cassader; Roberto Gambino; Giovanni Musso
Journal:  Gastroenterol Clin North Am       Date:  2012-12       Impact factor: 3.806

3.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

4.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

5.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

6.  Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet.

Authors:  Mikael Bjursell; Therése Admyre; Melker Göransson; Anna E Marley; David M Smith; Jan Oscarsson; Mohammad Bohlooly-Y
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

7.  Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats.

Authors:  Patrice D Cani; Cédric Dewever; Nathalie M Delzenne
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

Review 8.  Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome.

Authors:  Nathalie M Delzenne; Audrey M Neyrinck; Patrice D Cani
Journal:  Microb Cell Fact       Date:  2011-08-30       Impact factor: 5.328

Review 9.  Probiotics as Complementary Treatment for Metabolic Disorders.

Authors:  Mélanie Le Barz; Fernando F Anhê; Thibaut V Varin; Yves Desjardins; Emile Levy; Denis Roy; Maria C Urdaci; André Marette
Journal:  Diabetes Metab J       Date:  2015-08       Impact factor: 5.376

10.  Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity.

Authors:  Amandine Everard; Vladimir Lazarevic; Nadia Gaïa; Maria Johansson; Marcus Ståhlman; Fredrik Backhed; Nathalie M Delzenne; Jacques Schrenzel; Patrice François; Patrice D Cani
Journal:  ISME J       Date:  2014-04-03       Impact factor: 10.302

View more
  1 in total

1.  Microbial Reconstitution Reverses Early Female Puberty Induced by Maternal High-fat Diet During Lactation.

Authors:  Mengjie Wang; Youjie Zhang; David Miller; Naveen O Rehman; Xi Cheng; Ji-Youn Yeo; Bina Joe; Jennifer W Hill
Journal:  Endocrinology       Date:  2020-02-01       Impact factor: 4.736

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.